Need Help?

RNA-sequencing data of post-mortem brain tissue taken from individuals with SCA3 and controls

Spinocerebellar ataxia type 3 (SCA3) is the most common autosomal dominant inherited ataxia worldwide, caused by a CAG repeat expansion in the Ataxin-3 gene resulting in a polyglutamine (polyQ)-expansion in the corresponding protein. Here we have RNA-sequencing data from the cerebellum of individuals with SCA3 and matched controls.

Request Access

This is the data access policy for the human RNA-sequencing data associated with the study:A Novel SCA3 Knock-in Mouse Model Mimics the Human SCA3 Disease Phenotype Including Neuropathological, Behavioral, and Transcriptional Abnormalities Especially in Oligodendrocytes

1. The User Institution agrees to only use this data for academic research purposes. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy; In any publications based on these data, please describe how the data can be accessed, including the name of the hosting database (e.g., The European Genome-phenome Archive at the European Bioinformatics Institute) and its accession numbers, please also cite the original paper for which this data was generated for. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify the DAC within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify the DAC prior to any significant changes to the protocol for the Project. 14. The User Institution will notify the DAC as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. The DAC may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than James D. Mills and Eleonora Aronica. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of the Netherlands and shall be subject to the exclusive jurisdiction of the Netherlands courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001004241 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00006952505 fastq.gz 498.4 MB
EGAF00006952506 fastq.gz 518.7 MB
EGAF00006952507 fastq.gz 496.5 MB
EGAF00006952508 fastq.gz 516.4 MB
EGAF00006952509 fastq.gz 221.5 MB
EGAF00006952510 fastq.gz 232.0 MB
EGAF00006952511 fastq.gz 1.8 GB
EGAF00006952512 fastq.gz 1.8 GB
EGAF00006952513 fastq.gz 1.8 GB
EGAF00006952514 fastq.gz 1.8 GB
EGAF00006952515 fastq.gz 781.4 MB
EGAF00006952516 fastq.gz 822.9 MB
EGAF00006952517 fastq.gz 1.4 GB
EGAF00006952518 fastq.gz 1.5 GB
EGAF00006952519 fastq.gz 1.4 GB
EGAF00006952520 fastq.gz 1.5 GB
EGAF00006952521 fastq.gz 630.1 MB
EGAF00006952522 fastq.gz 664.8 MB
EGAF00006952523 fastq.gz 862.3 MB
EGAF00006952524 fastq.gz 905.7 MB
EGAF00006952525 fastq.gz 859.7 MB
EGAF00006952526 fastq.gz 902.4 MB
EGAF00006952527 fastq.gz 377.8 MB
EGAF00006952528 fastq.gz 399.4 MB
EGAF00006952529 fastq.gz 1.4 GB
EGAF00006952530 fastq.gz 1.4 GB
EGAF00006952531 fastq.gz 1.4 GB
EGAF00006952532 fastq.gz 1.4 GB
EGAF00006952533 fastq.gz 603.3 MB
EGAF00006952534 fastq.gz 635.0 MB
EGAF00006952535 fastq.gz 1.6 GB
EGAF00006952536 fastq.gz 1.7 GB
EGAF00006952537 fastq.gz 1.6 GB
EGAF00006952538 fastq.gz 1.7 GB
EGAF00006952539 fastq.gz 721.8 MB
EGAF00006952540 fastq.gz 764.2 MB
EGAF00006952541 fastq.gz 1.2 GB
EGAF00006952542 fastq.gz 1.2 GB
EGAF00006952543 fastq.gz 1.2 GB
EGAF00006952544 fastq.gz 1.2 GB
EGAF00006952545 fastq.gz 516.2 MB
EGAF00006952546 fastq.gz 541.4 MB
EGAF00006952547 fastq.gz 612.0 MB
EGAF00006952548 fastq.gz 636.3 MB
EGAF00006952549 fastq.gz 610.2 MB
EGAF00006952550 fastq.gz 634.0 MB
EGAF00006952551 fastq.gz 272.8 MB
EGAF00006952552 fastq.gz 285.4 MB
EGAF00006952553 fastq.gz 666.8 MB
EGAF00006952554 fastq.gz 696.5 MB
EGAF00006952555 fastq.gz 664.9 MB
EGAF00006952556 fastq.gz 694.2 MB
EGAF00006952557 fastq.gz 290.3 MB
EGAF00006952558 fastq.gz 305.8 MB
EGAF00006952559 fastq.gz 942.0 MB
EGAF00006952560 fastq.gz 982.7 MB
EGAF00006952561 fastq.gz 939.0 MB
EGAF00006952562 fastq.gz 979.2 MB
EGAF00006952563 fastq.gz 413.4 MB
EGAF00006952564 fastq.gz 434.5 MB
EGAF00006952565 fastq.gz 1.2 GB
EGAF00006952566 fastq.gz 1.3 GB
EGAF00006952567 fastq.gz 1.2 GB
EGAF00006952568 fastq.gz 1.3 GB
EGAF00006952569 fastq.gz 547.0 MB
EGAF00006952570 fastq.gz 574.9 MB
EGAF00006952571 fastq.gz 1.9 GB
EGAF00006952572 fastq.gz 2.0 GB
EGAF00006952573 fastq.gz 1.9 GB
EGAF00006952574 fastq.gz 2.0 GB
EGAF00006952575 fastq.gz 853.7 MB
EGAF00006952576 fastq.gz 902.7 MB
72 Files (70.5 GB)